In addition, upregulation of MEG3 could suppress tumour growth and cell proliferation in gemcitabine-resistant NSCLC by modulating PTEN signalling-mediated cell apoptosis [45]. The gene discussed is MEG3; the disease is non-small cell lung carcinoma.